Correspondence | Published:

Response to “Unexpected mutations after CRISPR–Cas9 editing in vivo

Nature Methods volume 15, pages 239240 (2018) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Nat. Methods 14, 547–548 (2017).

  2. 2.

    et al. Bioinformatics 28, 1811–1817 (2012).

  3. 3.

    et al. Nat. Biotechnol. 31, 213–219 (2013).

  4. 4.

    et al. Nat. Genet. 46, 912–918 (2014).

  5. 5.

    et al. Nat. Methods 12, 237–243 (2015).

  6. 6.

    , , & Nat. Biotechnol. 31, 230–232 (2013).

  7. 7.

    et al. Genome Res. 24, 132–141 (2014).

  8. 8.

    et al. Cell Stem Cell 15, 12–13 (2014).

  9. 9.

    et al. Cell Stem Cell 15, 27–30 (2014).

  10. 10.

    et al. Cell Stem Cell 15, 31–36 (2014).

  11. 11.

    et al. Nat. Methods 12, 479 (2015).

  12. 12.

    et al. Nat. Biotechnol. 33, 187–197 (2015).

  13. 13.

    et al. Nat. Biotechnol. 33, 179–186 (2015).

Download references

Acknowledgements

J.-S.K. is supported by a grant from the Institute for Basic Science (IBS-R021-D1).

Author information

Author notes

    • Sang-Tae Kim
    •  & Jeongbin Park

    These authors contributed equally to this work.

Affiliations

  1. Center for Genome Engineering, Institute for Basic Science, Seoul, South Korea.

    • Sang-Tae Kim
    • , Kyoungmi Kim
    •  & Jin-Soo Kim
  2. Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.

    • Jeongbin Park
    •  & Matthias Schlesner
  3. Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.

    • Jeongbin Park
  4. Department of Chemistry, Seoul National University, Seoul, South Korea.

    • Daesik Kim
    •  & Jin-Soo Kim
  5. Department of Chemistry, Hanyang University, Seoul, South Korea.

    • Sangsu Bae
  6. Bioinformatics and Omics Data Analytics, German Cancer Research Center (DKFZ), Heidelberg, Germany.

    • Matthias Schlesner

Authors

  1. Search for Sang-Tae Kim in:

  2. Search for Jeongbin Park in:

  3. Search for Daesik Kim in:

  4. Search for Kyoungmi Kim in:

  5. Search for Sangsu Bae in:

  6. Search for Matthias Schlesner in:

  7. Search for Jin-Soo Kim in:

Competing interests

J.-S.K. is a cofounder of and holds stocks in ToolGen, Inc., a company focused on therapeutic genome editing. All the other authors declare no competing financial interests.

Corresponding authors

Correspondence to Matthias Schlesner or Jin-Soo Kim.

Integrated supplementary information

Supplementary figures

  1. 1.

    1

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Figure 1 and Supplementary Notes 1–2

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nmeth.4554

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing